Category: Neuropharmacology
New Research: Neurofilament-Light Chain Is a Biomarker with High Translational Value
In the field of neurological diseases, there is a need for reliable biomarkers that can improve accuracy of a differential diagnosis and prognostic assessment. Neurofilament-light
Flortaucipir PET Shows Promise in Alzheimer’s Disease Diagnosis
In the April 27th issue of JAMA Neurology, researchers released new data that suggests 18F-flortaucipir positron emission topography (PET) can help clinicians diagnose late-stage Alzheimer’s Disease (AD).
Repetitive Negative Thinking Linked to Alzheimer’s Disease
According to a study published in Alzheimer’s & Dementia, cognitive decline and the deposition of harmful proteins in the brain linked to Alzheimer’s Disease (AD)
Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge, University
Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many different
Protein Shapes in Alzheimer’s Disease Research
Proteins — large molecules made up of amino acids — do most of the work in cells and are required for the structure, function, and
